Self-medication with pilocarpine among outpatients in a glaucoma clinic.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  British Journal of Ophthalmology

• Publication date

  1980-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjo.64.2.137PMID 7362816PMCID PMC1039365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A MEDICATION MONITOR AND FLUORESCEIN TECHNIQUE DESIGNED TO STUDY MEDICATION BEHAVIOUR

  1980influential reference
• Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen

  1978cited by this paper
• Do patients take digoxin?

  1978cited by this paper
• Compliance with Therapeutic Regimens

  1978cited by this paper
• Ocular therapeutics and pharmacology, 5th ed

  1978cited by this paper
• OCULAR THERAPEUTICS AND PHARMACOLOGY. FIFTH EDITION

  1977cited by this paper
• Patient compliance in glaucoma.

  1977cited by this paper
• Intraocular pressure control with twice-daily pilocarpine in two vehicle solutions.

  1977cited by this paper
• A comparison of patient compliance in treated vs untreated ocular hypertension.

  1976cited by this paper
• A comparison of patient compliance in treated vs untreated ocular hypertension.

  1976cited by this paper
• Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

  1975cited by this paper
• Medication monitor for ophthalmology.

  1974cited by this paper
• Pilocarpine and Intraocular Pressure: Duration of Effectiveness of 4% and 8% Pilocarpine Instillation

  1974cited by this paper
• Pilocarpine and intraocular pressure. Duration of effectiveness of 4 percent and 8 percent pilocarpine instillation.

  1974cited by this paper
• Patients' viewpoint of glaucoma therapy.

  1972cited by this paper
• Visual loss in a glaucoma clinic. I. Sociological considerations.

  1970cited by this paper
• The Inaccuracy in Using Interviews to Estimate Patient Reliability in Taking Medications at Home

  1969cited by this paper
• Evaluation of recall system for glaucoma suspects and patients.

  1967cited by this paper
• Doctor-patient relationship in glaucoma therapy.

  1966cited by this paper
• The doctor-patient relationship in glaucoma therapy.

  1965cited by this paper
• TREATMENT OF REFLUX OESOPHAGITIS.

  1964cited by this paper
• Failure of children to receive penicillin by mouth.

  1963cited by this paper
• Outpatient P.A.S. therapy.

  1957cited by this paper

• Development of the Latanoprost Solid Delivery System Based on Poly(l-lactide-co-glycolide-co-trimethylene carbonate) with Shape Memory for Glaucoma Treatment

  2023cites this paper
• Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control

  2021cites this paper
• Health Literacy, Medication Adherence, and Quality of Life in Patients With Uveitis

  2021cites this paper
• Individual factors increasing complexity of drug treatment—a narrative review

  2020cites this paper
• Knowledge, adherence and outcome in glaucoma

  2020cites this paper
• Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems

  2019cites this paper
• Histidine and Histidine‐Like Alkaloids

  2016cites this paper
• Système d'administration de médicament et procédés de traitement d'un glaucome à angle ouvert et de l'hypertension oculaire

  2013cites this paper
• A 2-hour Information Session and Patient Recall has Minimal Impact on Glaucoma-treatment Persistence in a Mature Practice

  2012cites this paper
• Administration à libération prolongée d'agents actifs pour traiter le glaucome et l'hypertension oculaire

  2012cites this paper
• Verzögerte freisetzung von wirkstoffen zur behandlung von glaukom oder okularer hypertonie

  2012cites this paper
• Glaucoma medication compliance issues in a Jamaican hospital eye clinic.

  2011cites this paper
• The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.

  2011cites this paper
• Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review

  2011cites this paper
• Anecortave Acetate: A New Approach for the Medical Treatment of Glaucoma

  2010cites this paper
• Revisiting the Issue of Compliance in Glaucoma

  2010cites this paper
• Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss.

  2010cites this paper
• Auditory training and challenges associated with participation and compliance.

  2010cites this paper
• First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results

  2010cites this paper
• Treatment adherence in ophthalmology and astrophysics.

  2010cites this paper
• First-year treatment patterns among new initiators of topical prostaglandin analogs

  2009cites this paper
• First-year treatment patterns among new initiators of topical prostaglandin analogs.

  2009cites this paper
• Methods in assessing drug compliance.

  2009cites this paper
• First-year treatment costs among new initiators of topical prostaglandin analogs

  2009cites this paper
• CHAPTER 22 – Medical treatment of glaucoma: general principles

  2009cites this paper
• An objective evaluation of eyedrop instillation in patients with glaucoma.

  2009cites this paper
• Will improvement of knowledge lead to improvement of compliance with glaucoma medication?

  2008cites this paper
• Will improvement of knowledge lead to improvement of compliance with glaucoma medication?

  2008cites this paper
• Improvement of therapy for amblyopia

  2007cites this paper
• An information session for glaucoma patients.

  2007cites this paper
• The TRAVATAN Dosing Aid accurately records when drops are taken.

  2007cites this paper
• Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives

  2007cites this paper
• Chapter 11 – Medical management of the glaucomas 2

  2007cites this paper
• Accuracy of an Electronic Monitoring and Reminder Device for Use With Travoprost Eye Drops

  2006cites this paper
• Health literacy and adherence to glaucoma therapy.

  2006cites this paper
• Noncompliance with Medical Treatment Among Glaucoma Patients in Oman—A Cross-Sectional Descriptive Study

  2005cites this paper
• A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure

  2005cites this paper
• Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.

  2005cites this paper
• Long-term effects of glaucoma therapy with 4% pilocarpine gel on corneal clarity and endothelial cell density

  2004cites this paper
• Causes Of Non-Compliance With Drug Regimens In Glaucoma Patients: A Qualitative Study

  2002cites this paper
• Patientencompliance in der Glaukomtherapie

  2002cites this paper
• New Glaucoma Medications in the Geriatric Population: Efficacy and Safety

  2002cites this paper
• [Patient compliance in glaucoma therapy].

  2002cites this paper
• Derivation of adherence metrics from electronic dosing records.

  2001cites this paper
• Ophthalmic emulsions and suspensions

  2001cites this paper
• The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trial.

  2000cites this paper
• Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.

  1999cites this paper
• Prolonged, Contemporaneous Administration of Pilocarpine and Timolol Increases the Aqueous Humor Pilocarpine Levels in Rabbits

  1999cites this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.

  1998cites this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.

  1998cites this paper
• Ecotypic differentiation for flood-tolerance and its morphological correlates in Chamaecrista fasciculata

  1997cites this paper
• Ocular inserts for topical delivery

  1995cites this paper
• Treatment compliance in childhood and adolescence

  1993cites this paper
• Prinzipien der medikamentösen Glaukomtherapie

  1993cites this paper
• Compliance Aids — Do They Work?

  1992cites this paper
• Visual impairment of open angle glaucomas at first presentation and after a five to ten year follow-up.

  1992cites this paper
• Practical problems with eye-drops among elderly ophthalmology outpatients.

  1992cites this paper
• The Effect of a Glaucoma Medication Reminder Cap on Patient Compliance and Intraocular Pressure

  1991cites this paper
• Long-term treatment with Pilogel/β-blocker in glaucoma patients

  1991cites this paper
• Long-term treatment with Pilogel/beta-blocker in glaucoma patients.

  1991cites this paper
• A study of the causes of non-compliance by patients prescribed eyedrops.

  1990cites this paper
• Efficacy and safety of the combination therapy Pilogel®/β-blocker: Interim results

  1989cites this paper
• Prodrugs for improved ocular drug delivery

  1989cites this paper
• Instilling eyedrops: difficulties experienced by patients following cataract surgery.

  1987cites this paper
• Ocular bioavailability of pilocarpic acid mono- and diester prodrugs as assessed by miotic activity in the rabbit

  1987cites this paper
• Ophthalmic beta-blockers since timolol.

  1987cites this paper
• Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

  1986cites this paper
• Compliance with topical pilocarpine treatment.

  1986cites this paper
• Pilocarpine prodrugs I. Synthesis, physicochemical properties and kinetics of lactonization of pilocarpic acid esters.

  1986cites this paper
• Compliance and prognosis in glaucoma.

  1985cites this paper
• Pilocarpic acid esters as novel sequentially labile pilocarpine prodrugs for improved ocular delivery.

  1985cites this paper
• [Drug therapy of chronic glaucoma with pilocarpine gel].

  1984cites this paper
• Zur medikamentösen Therapie des chronischen Glaukoms mit Pilokarpin-Gel*

  1984cites this paper
• Facilitating patient compliance in glaucoma therapy.

  1983cites this paper
• Compliance with treatment of patients with chronic open-angle glaucoma.

  1983cites this paper
• VISUAL ABILITY AND DRUG REGIMEN: RELATION TO COMPLIANCE WITH GLAUCOMA THERAPY

  1983cites this paper
• Theophyllines three times daily - when are the doses actually taken? - Pharmacokinetic ideals versus clinical practice.

  1982cites this paper
• Duration of effect of pilocarpine gel.

  1982cites this paper
• Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects.

  1982cites this paper
• Accuracy of patient interviews and estimates by clinical staff in determining medication compliance.

  1981cites this paper